Immunology
Gilead and Compugen enter exclusive license agreement for immunotherapy programme
December 20, 2023Research and Development Gilead Sciences, Immunology, License Agreement, compugen, immunology
Gilead Sciences and Compugen have announced that they have entered an exclusive license agreement for Compugen’s potential first in class, …
BioNTech achieves milestone at vaccine manufacturing site in Rwanda
December 19, 2023Manufacturing and Production BioNTech, Immunology, manufacturing, rwanda
BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in …
AstraZeneca to acquire Icosavax for up to $1.1bn
December 12, 2023Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines
AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …
GSK shares new data for RSV vaccine Arexvy
October 25, 2023Research and Development Arexvy, GSK, Immunology, RSV, Vaccine
GSK announced positive results from its phase 3 trial which assessed the immune response and safety of Arexvy, its respiratory …
AstraZeneca’s sBLA for FluMist Quadrivalent accepted by FDA
October 24, 2023Medical Communications AstraZeneca, FDA, FluMist, Immunology, flu vaccine, sBLA
AstraZeneca has announced that the US Food and Drug Administration (FDA) has accepted for review its Supplemental Biologics License Agreement …
GSK and Zhifei partner for shingles vaccine promotion in China
October 9, 2023Medical Communications GSK, Immunology, Shingrix, Vaccine, Zhifei, shingles
GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological Products to co-promote GSK’s shingles …
Janssen and Sanofi enter agreement for potential vaccine programme
October 5, 2023Business Services Immunology, Janssen, Sanofi, e coli, vaccines
Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …
Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine
October 5, 2023Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines
Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …
WHO recommends new vaccine for prevention of malaria in children
October 3, 2023Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine
The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria …
BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance
September 28, 2023Research and Development AMR, BactiVac, Immunology, vaccines
The University of Birmingham hosted Bacterial Vaccines Network has been awarded £1.4m in funding from the UK government to accelerate …
CDC Advisory Committee recommends Pfizer’s RSV vaccine
September 25, 2023Medical Communications Abrysvo, Immunology, Pfizer, RSV
Pfizer has announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has …
Exscientia enters AI drug discovery collaboration with Merck KGaA
September 20, 2023Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery
Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …
BioNTech and CEPI partner for development of mRNA mpox vaccine
September 19, 2023Research and Development BioNTech, CEPI, Immunology, mpox
BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advance the development of mRNA-based vaccine …
GSK and Save the Children extend partnership for unvaccinated children
September 15, 2023Medical Communications GSK, Immunology, childhood vaccination, vaccines
GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK …
ACM Biolabs shares positive results from phase 1 SARS-CoV-2 booster vaccine trial
September 5, 2023Research and Development ACM Biolabs, COVID-19, Immunology, SARS-CoV-2, Vaccine, clinical trial
ACM Biolabs has announced positive topline results from its phase 1 trial of ACM-001, an adjuvanted booster vaccine for SARS-CoV-2, …
